• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

VIDEO: Robert Frantz, MD, FACC, Discusses Costs Associated With Pulmonary Arterial Hypertension

Article

Robert Frantz, MD, FACC, Director, Pulmonary Hypertension Clinic, Mayo Clinic, says that the issue of cost is an important factor in treating patients with pulmonary arterial hypertension.

Robert Frantz, MD, FACC, Director, Pulmonary Hypertension Clinic, Mayo Clinic, says that the issue of cost is an important factor in treating patients with pulmonary arterial hypertension. Dr Frantz also says that patients with pulmonary arterial hypertension who contract a blood stream infection will most likely require costly hospitalization and run the risk of other health issues.

This video was taken on Sunday, October 21 at the CHEST 2012 conference in Atlanta, GA.

Related Videos
Luke Messac at ISC 2026
Ava Liberman at ISC 2026
Alison Holman at ISC 2026
Linda Stein Gold, MD
Dr. Emily Fisher at ISC 2026
Angelina Rose Wronski, RN, BS at ISC 2026
Maui Derm 2026
Donna Culton, MD
Philip Mease, MD
Jerry Shapiro, MD
Related Content
© 2026 MJH Life Sciences
AJMC®
All rights reserved.